Withdrawal of Registration Statement (rw)
May 17 2022 - 6:04AM
Edgar (US Regulatory)
QSAM
Biosciences, Inc.
9442
Capital of Texas Hwy N. Plaza 1, Suite 500
Austin,
Texas 78759
May
16, 2022
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
|
Re: |
QSAM
Biosciences, Inc. |
|
|
Request
to Withdraw Registration Statement on Form S-1 |
|
|
File
No. 333-261735 |
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), QSAM Biosciences, Inc., a Delaware corporation
(the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”)
consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Company’s Registration
Statement on Form S-1 together with all exhibits and amendments thereto (collectively, the “Registration Statement”). The
Registration Statement was originally filed with the Commission on December 17, 2021.
The
grounds upon which the Company is making this application for withdrawal are that the Company does not intend to proceed with the planned
registered offering of its shares of common stock and warrants under the Registration Statement at this time due to prevailing market
conditions. The Registration Statement has not been declared effective by the Commission, and no securities were sold or will be sold
under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the
protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act.
The
Company requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the
filing of the Registration Statement be credited for future use.
Additionally,
the Company requests that the Commission consent to withdrawal of the Company’s registration statement on Form 8-A12B (File No.
001-41337), filed with the Commission on March 28,2022, and declared effective on March 29, 2022.
Please
do not hesitate to contact Joel D. Mayersohn at 954-994-5426 or jmayersohn@dickinsonwright.com if you have any questions regarding the
foregoing or if we can provide any additional information.
|
|
Very
truly yours, |
|
|
QSAM
BIOSCIENCES, INC. |
|
|
|
|
|
|
By: |
/s/
Douglas Baum |
|
|
Name: |
Douglas
Baum |
|
|
Title: |
Chief
Executive Officer |
|
|
|
|
cc: |
Joel
D. Mayersohn, Esq |
|
|
Common Stock (QB) (USOTC:QSAM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Common Stock (QB) (USOTC:QSAM)
Historical Stock Chart
From Apr 2023 to Apr 2024